ANGLE plc

Equities

AGL

GB0034330679

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 09:05:27 27/06/2024 pm IST			5-day change	1st Jan Change
13.75 ^GBX	0.00%		-3.51%	+17.02%

21/06	Angle plc Raises Funds via Open Offer of Shares	MT
21/06	Angle says open offer raises proceeds of GBP500,000	AN

Angle says open offer raises proceeds of GBP500,000

June 21, 2024 at 03:24 pm IST

Angle PLC - Guildford, England-based liquid biopsy company - Receives valid applications for a total of 3.6 million open offer shares from qualifying shareholders, pursuant to open offer announced on June 5. Says that the open offer has raised gross proceeds of GBP500,000 at the issue price, which will be used to strengthen Angle's balance sheet. Adds that in aggregate, GBP9.3 million gross proceeds have been raised, pursuant to the placing, subscription, and open offer.

Current stock price: 13.94 pence, down 2.2% in London on Friday morning

12-month change: down 3.7%

By Holly Beveridge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	FTSE 100	8,180 PTS	-0.55%	-1.12%	-
	ANGLE PLC	13.75 GBX	0.00%	-3.51%	5.6Cr

Latest news about ANGLE plc

Angle plc Raises Funds via Open Offer of Shares	21/06	MT
Angle says open offer raises proceeds of GBP500,000	21/06	AN
EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows	05/06	AN
Angle plc to Raise GBP10.6 Million via Share Placing, Subscription, Open Offer	05/06	MT
ANGLE plc Reports Earnings Results for the Full Year Ended December 31, 2023	05/06	CI
ANGLE plc Provides Revenue Guidance for the First Half of 2024	05/06	CI
Bens Creek considers administration; Nexxen inks deal	17/05	AN
ANGLE plc Announces Publication of Study Using the Parsortix System	16/05	CI
Angle shares up on assay development deal with AstraZeneca	03/05	AN
Angle shares up on assay development deal with AstraZenaca	03/05	AN
Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca	03/05	MT
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	03/05	AN
Confident start before US jobs data	03/05	AN
InterContinental Hotels makes first-quarter progress	03/05	AN
ANGLE plc Announces New Commercial Agreement with Large Pharma	03/05	CI
No record close for FTSE 100; mixed trade in US	24/04	AN
No record close for FTSE 100; mixed trade in US	24/04	AN
Angle plc to Develop New Cancer Assay in Deal with AstraZeneca	24/04	MT
Angle shares jump on supplier agreement with with AstraZeneca	24/04	AN
AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook	24/04	AN
Angle PLC Announces New Commercial Agreement with AstraZeneca PLC	24/04	CI
Angle granted patents in US and Europe for Cellkeep slide	22/04	AN
Angle plc Secures European Patent for CellKeep Technology	22/04	MT
ANGLE plc Presents Parsortix HER2 Assay at AACR Annual Meeting 2024	08/04	CI
Transcript : ANGLE plc - Special Call	06/02

Chart ANGLE plc

Duration

Period

More charts

Company Profile

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

Sector

Advanced Medical Equipment & Technology

Calendar

10/07/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for ANGLE plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.1375 GBP

Average target price

0.685 GBP

Spread / Average Target

+398.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
ANGLE PLC	+17.02%	5.6Cr
SARTORIUS AG	-34.99%	1.49TCr
QUIDELORTHO CORPORATION	-54.52%	226.1Cr
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+16.54%	188.73Cr
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-11.85%	151.75Cr
BIOTAGE AB	+19.90%	118.81Cr
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-29.99%	87Cr
REVENIO GROUP OYJ	+2.21%	78Cr
CONTEC MEDICAL SYSTEMS CO.,LTD	-35.68%	75Cr
VAREX IMAGING CORPORATION	-29.32%	59Cr

Medical Diagnostic & Testing Equipment